NMD PHARMA NEUROMUSCULAR DISORDERS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79238525
Serial Number
79238525
Registration Number
5809155
Word Mark
NMD PHARMA NEUROMUSCULAR DISORDERS
Status
700 - Registered
Status Date
2019-07-23
Filing Date
2018-05-18
Registration Number
5809155
Registration Date
2019-07-23
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260721 - Diamonds that are completely or partially shaded.
Published for Opposition Date
2019-05-07
Attorney Name
Joel D. Leviton
Law Office Assigned Location Code
L20
Employee Name
KIDWELL WALKER, JACLYN
Statements
Certificate of Correction for Registration
In the statement, in the heading, " International Class 5 " is corrected per the restriction and the fnote dated 11/14/2019.
Indication of Colors claimed
The color(s) dark grey, light grey, and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMA" AND "NEUROMUSCULAR DISORDERS"
Description of Mark
The mark consists of the letters "NMD" in dark grey with a green diamond over the letter "M" followed by the word "PHARMA" in light grey over the wording "NEUROMUSCULAR DISORDERS" in light grey.
Goods and Services
Chemical-pharmaceutical preparations for the treatment of rare and genetic diseases; chemical-pharmaceutical preparations for the treatment of neurodegenerative diseases; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders; chemical-pharmaceutical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by compromised skeletal muscle excitability; diagnostic preparations for medical purposes; reagents for medical purposes [ and for research ] ; preparations for analysis for medical [ and research ] purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; pharmaceutical and medical preparations for acute hospital care, namely, chemical-pharmaceutical preparations for the reversal of neuromuscular blockade, chemical-pharmaceutical preparations for the treatment of intensive care unit acquired muscle weakness, chemical-pharmaceutical preparations for the treatment of neuromuscular disorders caused by infections
Goods and Services
Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-08-15
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-08-15
Primary Code
042
Current Trademark Owners
Party Name
NMD Pharma A/S
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
NMD Pharma A/S
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Party Name
NMD Pharma A/S
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Party Name
NMD Pharma A/S
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Joel D. Leviton
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1417454
International Registration Date
2018-05-18
International Publication Date
2018-08-09
International Renewal Date
2028-05-18
Auto Protection Date
2020-02-09
International Status
001 - Request for extension of protection established
International Status Date
2018-08-09
Priority Claimed In
True
Priority Claimed Date
2018-04-13
First Refusal In
True
Trademark Events
Event DateEvent Description
2018-08-09SN ASSIGNED FOR SECT 66A APPL FROM IB
2018-08-15NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-08-21APPLICATION FILING RECEIPT MAILED
2018-09-10ASSIGNED TO EXAMINER
2018-09-17NON-FINAL ACTION WRITTEN
2018-09-18NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2018-09-22REFUSAL PROCESSED BY MPU
2018-09-22NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2018-10-13REFUSAL PROCESSED BY IB
2019-03-04TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-03-04CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-03-05TEAS/EMAIL CORRESPONDENCE ENTERED
2019-03-18EXAMINERS AMENDMENT -WRITTEN
2019-03-18EXAMINERS AMENDMENT E-MAILED
2019-03-18NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2019-03-18EXAMINER'S AMENDMENT ENTERED
2019-03-18APPROVED FOR PUB - PRINCIPAL REGISTER
2019-04-17NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2019-04-17NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-04-17NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2019-04-30TEAS CHANGE OF CORRESPONDENCE RECEIVED
2019-05-03NOTIFICATION PROCESSED BY IB
2019-05-07PUBLISHED FOR OPPOSITION
2019-05-07OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-07-23REGISTERED-PRINCIPAL REGISTER
2019-08-23LIMITATION OF GOODS RECEIVED FROM IB
2019-10-23FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2019-11-14FINAL DISPOSITION PROCESSED
2019-11-14LIMITATION FROM THE IB EXAMINED AND ENTERED
2019-11-14FINAL DISPOSITION NOTICE SENT TO IB
2019-11-21CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2019-11-21CORRECTION UNDER SECTION 7 ¿ PROCESSED
2019-12-06FINAL DECISION TRANSACTION PROCESSED BY IB
2020-07-26PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
2020-09-03INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE